+34 963 586 020
  • English
    • English
    • Español
    • عربي

We advise all cancer patients to read this IMPORTANT book about the reality of cancer. CANCER: THE SURPRISING TRUTH. Its author is the prestigious molecular biologist Travis Christofferson. We recommend it for all cancer patients and of course for all physicians and oncologists.

Many of these treatments will require authorization from the Ministry of Health (Spanish Agency for Medicines and Health Products) in order to be administered under the legal figure of ‘COMPASSIONATE USE’.
For this purpose, a dossier will be sent with all the necessary information about the patient, their pathology and the drug to be used, while awaiting authorization for its use.

CANCER: THE SURPRISING TRUTH

Palliative Ozone Therapy

Studies using ozone were first initiated in animal models of cancer in the 1970s. Currently, ozone therapy is applied as an adjuvant against cancer. This is because it has been proven that ozone has an oxygenating effect on cancer cells, thus delaying the growth of neoplasms. Thanks to this alternative medicine, the following is achieved:

  • Metabolic regulation and decrease of lactic acidosis.
  • An increase in the level of antioxidants.
  • The transitory production of oxidation affects tumor cells, but not healthy cells.
  • A decrease in inflammatory processes.

In fact, there are studies carried out in patients diagnosed with cancer treated with ozone therapy whose results offer a considerable improvement in various immunological parameters (immunomodulation of the defensive system). If we take into account that one of the key factors of cancer is the inflammation caused by oxidants, which favors oncological processes, it can be said that the application of ozone gas on the organism attenuates its evolution.
Therefore, it can be concluded that the use of ozone therapy is an effective complement not only to reduce the side effects of cancer treatments such as chemotherapy and radiotherapy, but also to improve patients' quality of life by boosting their immune system.
In this regard, the University Hospital of Gran Canaria received an award for the study of its specialists of the Research and Chronic Pain Units on the benefits of ozone in the management of the toxicity of cancer treatments. This study is based mainly on the scientific evidence of cancer treatment with O3.
Research has revealed that human cancer cells in breast, lung and uterine tumors are inhibited by O3 therapy in vitro. Based on our experience with patients treated with ozone, we can affirm that the results indicate a notable improvement in the patient's quality of life, with a notable decrease in pain and tumor markers of between 18 to 45%. OBSERVATIONS: we cannot guarantee that this signifies an increase in survival, but it does imply an increase in the quality of life. Ozone therapy is administered by the following routes:

  • Rectal ozone therapy: in doses of 200 to 1,500 ce.
  • Vaginal ozone therapy: in doses of 1,000 to 3,000 ce.
  • Nasojejunal ozone therapy: (variable dose) (Protocol Dr. J.C. Perez Olmedo).
  • Intraperitoneal Ozone Therapy: (Dr. Juan C. Perez Olmedo)
  • Intravenous ozone therapy or major autohemotherapy with high doses (HOT)

Intraperitoneal Ozone Therapy: (Dr. Juan C. Perez Olmedo)

In which a plastic catheter is introduced intra-abdominal and held to the skin with a stitch and daily between 1,500 to 3,000 cubic centimeters of ozone is introduced daily, which is then expelled and emptied from the abdominal cavity. This is done for five days with the possibility of repeating a second week of treatment.

Intravenous ozone therapy or major autohemotherapy with high doses (HOT)

The results are generally quite good, with a marked improvement in the patient's quality of life, a decrease in pain, and often a decrease in tumor markers of between 18-45% . The peritoneal serosa is a large sponge that absorbs ozone formidably. This route of administration is particularly suitable for patients with liver cancer and peritoneal carcinomatosis but can also be used for any other cancerous site.

The hyperbaric ozone machine allows us to make 10, 20, or 30 daily passes of major autohemotherapy faster. Intravenous ozone is applied at a concentration of 70 micrograms/ml, with 150 mi of the patient's blood. (Dr. Lahodny, Austria, advises performing 10 passes/24h. for inflammatory diseases, 20 passes/24h. for autoimmune diseases, and 30 passes/24h. for oncological processes.)

In our experience, when more than ten passes are performed daily for five days a week, significant haemolysis is produced, which can lead to anemia with clinical repercussions. For example, a loss of 2 grams of hemoglobin after 15 sessions of HOT (high ozone therapy) carried out in 21 days.

BIBLIOGRAPHY

Request information without obligation

Request information without obligation, we will study your case with our medical team to give you an answer as soon as possible.

250
I accept the terms of use and privacy policy
mmoncoproject.com
Calendly